Calcitonin Gene-related Peptide Receptor Antagonist [EPC] - N0000193917
Pharmacologic Class Information
| Pharmacologic Code | N0000193917 |
| Pharmacologic Name | Calcitonin Gene-related Peptide Receptor Antagonist |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
| Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Calcitonin Gene-related Peptide Receptor Antagonist
The table contains 10 products whose active ingredient are classified under the same pharmacologic class Calcitonin Gene-related Peptide Receptor Antagonist [EPC].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0023-6501 | Ubrelvy | Non-Proprietary Name: Ubrogepant | Tablet | Oral | Allergan, Inc. | ACTIVE | |
| 63539-135 | Zavzpret | Non-Proprietary Name: Zavegepant | Spray | Nasal | U.s. Pharmaceuticals | ACTIVE | |
| 72618-3000 | Nurtec Odt | Non-Proprietary Name: Rimegepant Sulfate | Tablet, Orally Disintegrating | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
| 0074-7094 | Qulipta | Non-Proprietary Name: Atogepant | Tablet | Oral | Abbvie Inc. | ACTIVE | |
| 0074-7095 | Qulipta | Non-Proprietary Name: Atogepant | Tablet | Oral | Abbvie Inc. | ACTIVE | |
| 0023-6498 | Ubrelvy | Non-Proprietary Name: Ubrogepant | Tablet | Oral | Allergan, Inc. | ACTIVE | |
| 0069-3500 | Zavzpret | Non-Proprietary Name: Zavegepant | Spray | Nasal | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
| 85766-096 | Nurtec Odt | Non-Proprietary Name: Rimegepant Sulfate | Tablet, Orally Disintegrating | Oral | Sportpharm, Inc. Dba Sportpharm | ACTIVE | |
| 0074-7096 | Qulipta | Non-Proprietary Name: Atogepant | Tablet | Oral | Abbvie Inc. | ACTIVE | |
| 72618-3001 | Nurtec Odt | Non-Proprietary Name: Rimegepant Sulfate | Tablet, Orally Disintegrating | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE |